Pauls Matthew
CIK 0001573429
CHIEF EXECUTIVE OFFICERDirector
Filings
15
Latest May 18, 2026
Issuers covered
3
Showing
15 of 15
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 20% | -8.8% | -3.5% | +5.2% | -21.7% |
| 90 days | 3 | 33% | -1.2% | -0.6% | +13.8% | -16.7% |
| 180 days | 3 | 100% | +21.6% | +21.2% | +33.1% | +10.4% |
| 365 days | 3 | 67% | -1.6% | +34.6% | +57.7% | -97.2% |
Issuers
Companies where Pauls Matthew has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SVRA | Savara Inc | 6 | Dec 16, 2025 |
| SLNO | Soleno Therapeutics Inc | 5 | May 18, 2026 |
| PTHS | Pelthos Therapeutics Inc. | 4 | Apr 6, 2026 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|